Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes in Patients with High-Dose Methotrexate Toxicity Treated with Vs. without Glucarpidase

Shruti Gupta, Ann LaCasce, Rebecca Karp Leaf, Sarah Kaunfer, David E Leaf

Blood (2023) 142 (Supplement 1): 268.

https://doi.org/10.1182/blood-2023-189432

Published: 2023

Journal Articles

The Relationship between Protoporphyrin IX and Platelet Count in the Protoporphyrias

Rebecca Karp Leaf, Paul Yanning Jiang, R. Jay Goddu, Benny Tran, Lina Rebeiz, Sarina Elmariah, Pamela G Hodges, Jennifer Mead, John Trinidad, Behnam Saberi, Mark D. Fleming, Sarah Ducamp, Karl Anderson, Amy Dickey

Blood (2023) 142 (Supplement 1): 5230.

https://doi.org/10.1182/blood-2023-180928

Published: 2023

Journal Articles

Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

Zain Virk, Rebecca Karp Leaf, David J Kuter, Katayoon Goodarzi, Nathan T. Connell, Jean M. Connors, Hanny Al-Samkari

Blood (2023) 142 (Supplement 1): 392.

https://doi.org/10.1182/blood-2023-179601

Published: 2023

Journal Articles

How I treat erythropoietic protoporphyria and X-linked protoporphyria

Rebecca Karp Leaf, Amy K. Dickey

Blood (2023) 141 (24): 2921–2931.

https://doi.org/10.1182/blood.2022018688

Published: 2023

Journal Articles

Clinical Experience with Afamelanotide for the Protoporphyrias in the United States

Rebecca Karp Leaf, Sarina Elmariah, Paul Yanning Jiang, Jennifer Mead, Pamela Hodges, Sarah Elizabeth Valiante, Francesca Mernick, Karl E Anderson, Amy Dickey

Blood (2022) 140 (Supplement 1): 2201–2202.

https://doi.org/10.1182/blood-2022-163566

Published: 2022

Journal Articles

Predictors of Mortality and Outcomes of Liver Transplant in Spur Cell Hemolytic Anemia

Zain M Virk, Arpan A Patel, Rebecca Karp Leaf, Hanny Al-Samkari

Blood (2021) 138 (Supplement 1): 1995.

https://doi.org/10.1182/blood-2021-146243

Published: 2021

Journal Articles

Thrombopoietin Level Predicts Response to Treatment with Romiplostim in Chemotherapy-Induced Thrombocytopenia

Andrew B Song, Katayoon Goodarzi, Rebecca Karp Leaf, David J. Kuter, Hanny Al-Samkari

Blood (2021) 138 (Supplement 1): 584.

https://doi.org/10.1182/blood-2021-145931

Published: 2021

Journal Articles

Pulmonary Hypertension Is Associated with Poor Outcomes in Patients with Myeloproliferative Neoplasms and Cardiovascular Disease

Orly Leiva, Siyang Ren, Donna S. Neuberg, Ankeet Bhatt, Andrew Jenkins, Rachel P. Rosovsky, Rebecca Karp Leaf, Katayoon Goodarzi, Gabriela Hobbs

Blood (2021) 138 (Supplement 1): 3653.

https://doi.org/10.1182/blood-2021-149799

Published: 2021

Journal Articles

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Orly Leiva, Umberto Campia, Julia Snyder, Briana Barns, Samantha Rizzo, Candrika Khairani, Hanny Al-Samkari, Rebecca Karp Leaf, Rachel P. Rosovsky, Katayoon Goodarzi, Amir T. Fathi, Samuel Z. Goldhaber, Gregory Piazza, Gabriela Hobbs

Blood (2021) 138 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2021-151801

Published: 2021

Journal Articles

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Orly Leiva, MD, Olesya Baker, PhD, Andrew M. Brunner, Hanny Al-Samkari, MD, Rebecca Karp Leaf, MD, Rachel P. Rosovsky, MD MPH, Amir T. Fathi, MD, James I Weitzman, MD, Larissa Bornikova, MD, Valentina Nardi, MD, Gabriela S. Hobbs, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-137311

Published: 2020

Journal Articles

Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases

Rebecca Karp Leaf, MD, Christopher Ferreri, MD, Kerry Lynn Reynolds, MD, Deepa Rangachari, MD, James Mier, MD, Wesley Witteles, MD, George Ansstas, MD, Theodora Anagnostou, MD, Leyre Zubiri, MD, Zofia Piotrowska, MD, Thein H. Oo, MD, David Iberri, MD, Mark Yarchoan, MDPhD, April Salama, MD, Osama Rahma, David Leaf, MD

Blood (2018) 132 (Supplement 1): 1037.

https://doi.org/10.1182/blood-2018-99-111186

Published: 2018

Journal Articles

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

Blood (2018) 131 (25): 2836–2845.

https://doi.org/10.1182/blood-2017-05-780239

Published: 2018

Includes: Supplemental data

Journal Articles

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia

Blood (2017) 129 (13): 1791–1801.

https://doi.org/10.1182/blood-2016-07-730614

Published: 2017

Includes: Supplemental data

Journal Articles

MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs

Blood (2016) 128 (22): 2871.

https://doi.org/10.1182/blood.V128.22.2871.2871

Published: 2016

Journal Articles

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma

Salvia Jain, MD, Abigail J. Washington, BA, Rebecca Karp Leaf, MD, Parul Bhargava, MD, Rachael Clark, MD PhD, Thomas S. Kupper, MD, Dina Stroopinsky, PhD, Athalia Rachel Pyzer, MD, Leandra Cole, BA, Myrna R. Nahas, MD, Arie Apel, MD, Jacalyn Rosenblatt, MD, Jon Arnason, MD, Donald Kufe, MD, David E. Avigan, MD

Blood (2016) 128 (22): 4175.

https://doi.org/10.1182/blood.V128.22.4175.4175

Published: 2016

Journal Articles

A Novel Dendritic Cell-Derived Vaccine in Multiple Myeloma

Rebecca Karp Leaf, MD, Dina Stroopinsky, PhD, Athalia Rachel Pyzer, MD, Ada M. Kruisbeek, PhD, Sandra Van Wetering, PhD, Abigail J. Washington, BA, Leandra Cole, BA, Myrna R. Nahas, MD, Salvia Jain, MD, Arie Apel, MD, Jon Arnason, MD, Ayad Hamdan, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD

Blood (2016) 128 (22): 4484.

https://doi.org/10.1182/blood.V128.22.4484.4484

Published: 2016

Journal Articles

Phase I Clinical Trial Evaluating Abatacept in Patient with Steroid-Refractory Chronic Graft Versus Host Disease

Blood (2016) 128 (22): 387.

https://doi.org/10.1182/blood.V128.22.387.387

Published: 2016

Journal Articles

Acute Myeloid Leukemia Cells Export c-Myc in Extracellular Vesicles Driving a Proliferation of Immune-Suppressive Myeloid-Derived Suppressor Cells

Athalia Rachel Pyzer, MD, Dina Stroopinsky, PhD, Hasan Rajabi, PhD, Abigail J. Washington, BA, Leandra Cole, BA, Salvia Jain, MD, Ashujit Tagde, PhD BPharm, Arie Apel, MD, Malgorzata McMasters, MD, James D. Levine, MD, Robin Joyce, MD, Jon Arnason, MD, Poorvi Somaiya, Rebecca Karp Leaf, MD, Myrna R. Nahas, MD, Donald Küfe, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD

Blood (2016) 128 (22): 703.

https://doi.org/10.1182/blood.V128.22.703.703

Published: 2016

Journal Articles

MUC-1 Regulates MiR34a Expression in Acute Myeloid Leukemia Cells Resulting in an Accumulation of Granulocytic Myeloid-Derived Suppressor Cells

Blood (2015) 126 (23): 643.

https://doi.org/10.1182/blood.V126.23.643.643

Published: 2015

Journal Articles

Pure Red Cell Aplasia after ABO-Mismatched Allogeneic Stem Cell Transplantation Treated with Therapeutic Plasma Exchange and Rituximab

Rebecca Karp, MD, Jon E. Arnason, MD, Jacalyn Rosenblatt, David Avigan, MD, Robin Joyce, MD, Myrna Rita Nahas, MD, Erik Uhlmann, MD, Ayad Hamdan, MD

Blood (2015) 126 (23): 5453.

https://doi.org/10.1182/blood.V126.23.5453.5453

Published: 2015

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical Outcomes in Patients with High-Dose Methotrexate Toxicity Treated with Vs. without Glucarpidase

The Relationship between Protoporphyrin IX and Platelet Count in the Protoporphyrias

Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

How I treat erythropoietic protoporphyria and X-linked protoporphyria

Clinical Experience with Afamelanotide for the Protoporphyrias in the United States

Predictors of Mortality and Outcomes of Liver Transplant in Spur Cell Hemolytic Anemia

Thrombopoietin Level Predicts Response to Treatment with Romiplostim in Chemotherapy-Induced Thrombocytopenia

Pulmonary Hypertension Is Associated with Poor Outcomes in Patients with Myeloproliferative Neoplasms and Cardiovascular Disease

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia

MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma

A Novel Dendritic Cell-Derived Vaccine in Multiple Myeloma

Phase I Clinical Trial Evaluating Abatacept in Patient with Steroid-Refractory Chronic Graft Versus Host Disease

Acute Myeloid Leukemia Cells Export c-Myc in Extracellular Vesicles Driving a Proliferation of Immune-Suppressive Myeloid-Derived Suppressor Cells

MUC-1 Regulates MiR34a Expression in Acute Myeloid Leukemia Cells Resulting in an Accumulation of Granulocytic Myeloid-Derived Suppressor Cells

Pure Red Cell Aplasia after ABO-Mismatched Allogeneic Stem Cell Transplantation Treated with Therapeutic Plasma Exchange and Rituximab

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only